Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-97-001434
Filing Date
1997-03-28
Accepted
1997-03-28 00:00:00
Documents
5
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 DIACRIN, INC. 10-K 185998
2 1994 DIRECTORS STOCK OPTION PLAN EX-10.10 16523
3 COMPUTATION OF PRO FORMA NET LOSS PER COMMON SHARE EX-11 2938
4 CONSENT OF ARTHUR ANDERSEN LLP EX-23 563
5 FINANCIAL DATA SCHEDULE EX-27 2169
  Complete submission text file 0000950135-97-001434.txt   210132
Mailing Address BLDG 96 13TH ST CHARLESTOWN NAVY YARD CHARLESTOWN MA 02129
Business Address BLDG 96, 13TH ST CHARLESTOWN NAVY YARD CHARLESTOWN MA 02129 6172429100
DIACRIN INC /DE/ (Filer) CIK: 0000887137 (see all company filings)

EIN.: 223016912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20139 | Film No.: 97567522
SIC: 2836 Biological Products, (No Diagnostic Substances)